Eli Lilly and Co
US.LLY
1,149.36
-10.24
-0.88%
Eli Lilly and Co
1,149.36
-10.24
-0.88%
Collector offline (last heartbeat: 19176s ago)
· 2026-09-04 20:02
Pre-market
1,150.65
-0.77%
After-hours
1,146.65
-0.24%
Overnight
1,158.00
-0.14%
Recent news
-
DBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,550Market Newswire · 8/25
-
MMAG: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - MR CHEAH MIN LLYBursa Malaysia · 1/9
-
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400Market Newswire · 9/1
-
Citi Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,600Market Newswire · 9/1
-
U.S. Stock Market Movements | Eli Lilly and Co (LLY.US) Rises 1.69% as Alzheimer's Blood Test Wins FDA ApprovalZhitong Finance · 9/1
-
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,440Market Newswire · 9/1
-
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400Market Newswire · 8/31
-
MMAG: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - MR CHEAH MIN LLY (Amended Announcement)Bursa Malaysia · 1/12
-
Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,385Market Newswire · 9/1
-
J.P. Morgan Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,400Market Newswire · 9/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-09-04 20:02:22
For reference only, not investment advice.